glp-1 news today 2025 november 5 Beyond GLP-1: the next wave of weight-loss medication innovation Lilly, chasing Novo, expects second-quarter

Eli Lilly has terminated its partnership with Noom after the telehealth platform continued to sell knockoff versions of blockbuster GLP-1 drugs

We will work closely with the city to build on its revitalization plan and bring to life our shared vision of a thriving, healthy addition to the Old Fourth Ward, said Candice L

This approach may involve advocating for continued or augmented treatment, or implementing combination therapies that offer potential synergistic or pleiotropic effects, such as GLP-1 RAs, dual agonists, statins or anti-hypertensive medication to optimise patient outcomes, and address multiple composites of the disease, particularly in relation to cardiovascular outcomes

10.1016/j.jot.2019.10.006 J

he won two years in a row